Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Impairment of myocardial protection in type 2 diabetic patients.

Lee TM, Chou TF.

J Clin Endocrinol Metab. 2003 Feb;88(2):531-7.

PMID:
12574175
2.

Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes.

Johnson JA, Majumdar SR, Simpson SH, Toth EL.

Diabetes Care. 2002 Dec;25(12):2244-8.

PMID:
12453968
3.

Effects of treatment with sulfonylurea drugs or insulin on ischemia-induced myocardial dysfunction in type 2 diabetes.

Scognamiglio R, Avogaro A, Vigili de Kreutzenberg S, Negut C, Palisi M, Bagolin E, Tiengo A.

Diabetes. 2002 Mar;51(3):808-12.

5.
6.

Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channels.

Dabrowski M, Wahl P, Holmes WE, Ashcroft FM.

Diabetologia. 2001 Jun;44(6):747-56.

PMID:
11440368
7.

Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide.

Mocanu MM, Maddock HL, Baxter GF, Lawrence CL, Standen NB, Yellon DM.

Circulation. 2001 Jun 26;103(25):3111-6.

8.
9.

Molecular basis of electrocardiographic ST-segment elevation.

Li RA, Leppo M, Miki T, Seino S, Marbán E.

Circ Res. 2000 Nov 10;87(10):837-9.

11.

Myocardial infarction in diabetic vs non-diabetic subjects. Survival and infarct size following therapy with sulfonylureas (glibenclamide)

Klamann A, Sarfert P, Launhardt V, Schulte G, Schmiegel WH, Nauck MA.

Eur Heart J. 2000 Feb;21(3):220-9.

PMID:
10639304
12.
13.

Relation between sulfonylurea therapy, complications, and outcome for elderly patients with acute myocardial infarction.

Jollis JG, Simpson RJ Jr, Cascio WE, Chowdhury MK, Crouse JR 3rd, Smith SC Jr.

Am Heart J. 1999 Nov;138(5 Pt 1):S376-80. No abstract available.

PMID:
10539800
14.

Differential sensitivity of beta-cell and extrapancreatic K(ATP) channels to gliclazide.

Gribble FM, Ashcroft FM.

Diabetologia. 1999 Jul;42(7):845-8.

PMID:
10440127
15.

Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K(ATP) channel.

Ashfield R, Gribble FM, Ashcroft SJ, Ashcroft FM.

Diabetes. 1999 Jun;48(6):1341-7.

PMID:
10342826
17.

Sulfonylureas and ischaemic preconditioning; a double-blind, placebo-controlled evaluation of glimepiride and glibenclamide.

Klepzig H, Kober G, Matter C, Luus H, Schneider H, Boedeker KH, Kiowski W, Amann FW, Gruber D, Harris S, Burger W.

Eur Heart J. 1999 Mar;20(6):439-46.

PMID:
10213347
18.

Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction.

Garratt KN, Brady PA, Hassinger NL, Grill DE, Terzic A, Holmes DR Jr.

J Am Coll Cardiol. 1999 Jan;33(1):119-24.

19.
20.

Supplemental Content

Support Center